RESUMEN
Pancreatic secretory trypsin inhibitor Kazal type 1 (SPINK1) is a 6420 Da peptide produced by the pancreas, but also by several other tissues and many tumors. Some mutations of the SPINK1 gene, like the one causing amino acid change N34S, have been shown to confer susceptibility to recurrent or chronic pancreatitis. Detection of such variants are therefore of clinical utility. So far SPINK1 variants have been determined by DNA techniques. We have developed and validated an immunocapture-liquid chromatography-mass spectrometric (IC-LC-MS) assay for the detection and quantification of serum SPINK1, N34S-SPINK1, and P55S-SPINK1. We compared this method with a time-resolved immunofluorometric assay (TR-IFMA) for serum samples and primer extension analysis of DNA samples. We used serum and DNA samples from patients with acute pancreatitis, renal cell carcinoma, or benign urological conditions. With the help of a zygosity score calculated from the respective peak areas using the formula wild-type (wt) SPINK1/(variant SPINK1 + wt SPINK1), we were able to correctly characterize the heterozygotes and homozygotes from the samples with DNA information. The score was then used to characterize the apparent zygosity of the samples with no DNA characterization. The IC-LC-MS method for SPINK1 was linear over the concentration range 0.5-1000 µg/L. The limit of quantitation (LOQ) was 0.5 µg/L. The IC-LC-MS and the TR-IFMA assays showed good correlation. The median zygosity score was 1.00 (95% CI 0.98-1.01, n = 11), 0.55 (95% CI 0.43-0.61, n = 14), and 0.05 (range 0.04-0.07, n = 3) for individuals found to be wt, heterozygous, and homozygous, respectively, for the N34S-SPINK1 variant by DNA analysis. When DNA samples are not available, this assay facilitates identification of the N34S- and P55S-SPINK1 variants also in archival serum samples.
Asunto(s)
Cromatografía de Afinidad/métodos , Espectrometría de Masas/métodos , Mutación , Inhibidor de Tripsina Pancreática de Kazal/sangre , Inhibidor de Tripsina Pancreática de Kazal/genética , Enfermedad Aguda , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Renales/sangre , Carcinoma de Células Renales/genética , Femenino , Humanos , Neoplasias Renales/sangre , Neoplasias Renales/genética , Límite de Detección , Masculino , Persona de Mediana Edad , Pancreatitis/sangre , Pancreatitis/genética , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Adulto JovenRESUMEN
Abalone (Haliotis) undergoes a period of reproductive maturation, followed by the synchronous release of gametes, called broadcast spawning. Field and laboratory studies have shown that the tropical species Haliotis asinina undergoes a two-week spawning cycle, thus providing an excellent opportunity to investigate the presence of endogenous spawning-associated peptides. In female H. asinina, we have isolated a peptide (5145 Da) whose relative abundance in hemolymph increases substantially just prior to spawning and is still detected using reverse-phase high-performance liquid chromatography chromatograms up to 1-day post-spawn. We have isolated this peptide from female hemolymph as well as samples prepared from the gravid female gonad, and demonstrated through comparative sequence analysis that it contains features characteristic of Kazal-type proteinase inhibitors (KPIs). Has-KPI is expressed specifically within the gonad of adult females. A recombinant Has-KPI was generated using a yeast expression system. The recombinant Has-KPI does not induce premature spawning of female H. asinina when administered intramuscularly. However it displays homomeric aggregations and interaction with at least one mollusc-type neuropeptide (LRDFVamide), suggesting a role for it in regulating neuropeptide endocrine communication. This research provides new understanding of a peptide that can regulate reproductive processes in female abalone, which has the potential to lead to the development of greater control over abalone spawning. The findings also highlight the need to further explore abalone reproduction to clearly define a role for novel spawning-associated peptide in sexual maturation and spawning. Copyright © 2016 European Peptide Society and John Wiley & Sons, Ltd.
Asunto(s)
Regulación del Desarrollo de la Expresión Génica , Moluscos/crecimiento & desarrollo , Neuropéptidos/metabolismo , Ovario/metabolismo , Maduración Sexual/genética , Inhibidor de Tripsina Pancreática de Kazal/metabolismo , Secuencia de Aminoácidos , Animales , Clonación Molecular , Femenino , Hemolinfa/química , Modelos Moleculares , Moluscos/genética , Moluscos/metabolismo , Neuropéptidos/genética , Ovario/crecimiento & desarrollo , Pichia/genética , Pichia/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Reproducción/genética , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Transducción de Señal , Inhibidor de Tripsina Pancreática de Kazal/química , Inhibidor de Tripsina Pancreática de Kazal/genética , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificaciónRESUMEN
Low-molecular-mass trypsin inhibitor (clTI-1; chicken liver Trypsin Inhibitor-1) was purified from chicken liver by extraction with perchloric acid, ammonium sulfate precipitation, a combination of ethanol-acetone fractionation followed by gel filtration, ion-exchange chromatography and RP-HPLC on a C18 column. The inhibitor occurs in two isoforms with molecular masses of 5938.56 and 6026.29 Da (determined by MALDI TOFF mass spectrometry). The complete amino acid sequences of both isoforms were determined (UniProtKB/Swiss-Prot P85000; ISK1L_CHICK). The inhibitor shows a high homology to Kazal-type family inhibitors, especially to trypsin/acrosin inhibitors and pancreatic secretory trypsin inhibitors. clTI-1 inhibits both bovine and porcine trypsin (K(a)=1.1 x 10(9) M(-1) and 2.5 x 10(9) M(-1), respectively). Significant differences were shown in the inhibition of the anionic and cationic forms of chicken trypsin (K(a)=4.5 x 10(8) M(-1) and 1.2 x 10(10) M(-1)). Weak interaction with human plasmin (K(a)=1.2 x 10(7) M(-1)) was also revealed.
Asunto(s)
Pollos , Hígado/química , Serina Endopeptidasas/metabolismo , Inhibidores de Serina Proteinasa/química , Inhibidores de Serina Proteinasa/aislamiento & purificación , Inhibidor de Tripsina Pancreática de Kazal/química , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Secuencia de Aminoácidos , Animales , Humanos , Datos de Secuencia Molecular , Inhibidores de Serina Proteinasa/farmacología , Inhibidor de Tripsina Pancreática de Kazal/farmacologíaRESUMEN
The turkey reproductive tract and seminal plasma contain a serine proteinase inhibitor that seems to be unique for the reproductive tract. Our experimental objective was to isolate, characterize and cDNA sequence the Kazal family proteinase inhibitor from turkey seminal plasma and testis. Seminal plasma contains two forms of a Kazal family inhibitor: virgin (Ia) represented by an inhibitor of moderate electrophoretic migration rate (present also in the testis) and modified (Ib, a split peptide bond) represented by an inhibitor with a fast migration rate. The inhibitor from the seminal plasma was purified by affinity, ion-exchange and reverse phase chromatography. The testis inhibitor was purified by affinity and ion-exchange chromatography. N-terminal Edman sequencing of the two seminal plasma inhibitors and testis inhibitor were identical. This sequence was used to construct primers and obtain a cDNA sequence from the testis. Analysis of a cDNA sequence indicated that turkey proteinase inhibitor belongs to Kazal family inhibitors (pancreatic secretory trypsin inhibitors, mammalian acrosin inhibitors) and caltrin. The turkey seminal plasma Kazal inhibitor belongs to low molecular mass inhibitors and is characterized by a high value of the equilibrium association constant for inhibitor/trypsin complexes.
Asunto(s)
Proteínas Aviares/química , Semen/química , Inhibidor de Tripsina Pancreática de Kazal/química , Pavos , Secuencia de Aminoácidos , Animales , Proteínas Aviares/genética , Proteínas Aviares/aislamiento & purificación , Secuencia de Bases , Clonación Molecular , ADN Complementario/química , Masculino , Datos de Secuencia Molecular , Alineación de Secuencia , Testículo/química , Inhibidor de Tripsina Pancreática de Kazal/genética , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Pavos/genéticaRESUMEN
BACKGROUND AND OBJECTIVE: Porphyromonas gingivalis has been implicated as the major pathogen of periodontitis in adults. This organism produces an array of virulence factors, of which cysteine proteinases, referred to as gingipains K and R, are believed to play a crucial role in pathogenicity. The aim of this study was to investigate the susceptibility of gingipains K and R to inhibition by a pancreatic secretory trypsin inhibitor. MATERIAL AND METHODS: Enzyme activities were measured spectrophotometrically using chromogenic turnover substrates. To estimate the value of the association constant (Ka), constant amounts of enzyme were reacted with increasing amounts of inhibitor to reach equilibrium. The Ka was calculated by fitting the experimental data to the given equation. RESULTS: In this study it was shown that gingipains are susceptible to pancreatic Kazal-type trypsin inhibitors (pancreatic secretory trypsin inhibitors). Bovine pancreatic secretory trypsin inhibitor, having an Arg residue at the P1 position of the reactive site, specifically inhibited the activity of the Arg-specific cysteine proteinase gingipain R, whereas porcine inhibitor, possessing a Lys residue at the P1 position, exhibited activity only against the Lys-specific cysteine proteinase gingipain K. The Ka values for the inhibitor-proteinase interaction were 1.6 x 10(6) m(-1) and 2.0 x 10(4) m(-1) for gingipain R and gingipain K, respectively. CONCLUSION: This finding is the first demonstration of the inhibitory potency of the Kazal-type specific trypsin inhibitors against cysteine proteinases. These discoveries open new possibilities for the use of naturally occurring inhibitors, displaying activity across enzyme families, as a model in designing new molecules of therapeutic significance.
Asunto(s)
Adhesinas Bacterianas/metabolismo , Cisteína Endopeptidasas/metabolismo , Inhibidores de Cisteína Proteinasa/metabolismo , Porphyromonas gingivalis/enzimología , Inhibidor de Tripsina Pancreática de Kazal/metabolismo , Animales , Bovinos , Pollos , Inhibidores de Cisteína Proteinasa/aislamiento & purificación , Cisteína-Endopeptidasas Gingipaínas , Porcinos , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Factores de VirulenciaRESUMEN
The complete amino acid sequence obtained by electrospray ionization tandem mass spectrometry of the proteinase inhibitor CmPI-II isolated from Cenchritis muricatus is described. CmPI-II is a 5480-Da protein with three disulfide bridges that inhibits human neutrophil elastase (HNE) (K(i) 2.6+/-0.2 nM), trypsin (K(i) 1.1+/-0.9 nM), and other serine proteinases such as subtilisin A (K(i) 30.8+/-1.2 nM) and pancreatic elastase (K(i) 145.0+/-4.4 nM); chymotrypsin, pancreatic and plasma kallikreins, thrombin and papain are not inhibited. CmPI-II shares homology with the Kazal-type domain and may define a new group of 'non-classical' Kazal inhibitors according to its Cys(I)-Cys(V) disulfide bridge position. The 3D model of CmPI-II exhibits similar secondary structure characteristics to Kazal-type inhibitors and concurs with circular dichroism experiments. A 3D model of the CmPI-II/HNE complex provides a structural framework for the interpretation of its experimentally determined K(i) value. The model shows both similar and different contacts at the primary binding sites in comparison with the structure of turkey ovomucoid third domain (OMTKY3)/HNE used as template. Additional contacts calculated at the protease-inhibitor interface could also contribute to the association energy of the complex. This inhibitor represents an exception in terms of specificity owing to its ability to strongly inhibit elastases and trypsin.
Asunto(s)
Modelos Moleculares , Inhibidor de Tripsina Pancreática de Kazal/química , Secuencia de Aminoácidos , Animales , Dicroismo Circular , Electroforesis en Gel de Poliacrilamida , Humanos , Elastasa de Leucocito/antagonistas & inhibidores , Datos de Secuencia Molecular , Homología de Secuencia de Aminoácido , Caracoles , Espectrometría de Masa por Ionización de Electrospray , Espectrofotometría Ultravioleta , Espectrometría de Masas en Tándem , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Inhibidor de Tripsina Pancreática de Kazal/farmacologíaRESUMEN
It has traditionally been believed that only the human collagenases (matrix metalloproteinase-1, -8, and -13) are capable of initiating the degradation of collagens. Here, we show that human trypsin-2 is also capable of cleaving the triple helix of human cartilage collagen type II. We purified human trypsin-2 and tumor-associated trypsin inhibitor by affinity chromatography whereas collagen type II was purified from cartilage extracts using pepsin digestion and salt precipitation. Degradation of type II collagen and gelatin by trypsin-2 was demonstrated with sodium dodecyl sulfate-polyacrylamide gel electrophoresis, zymography, and mass spectrometry, and tumor-associated trypsin inhibitor specifically inhibited this degradation. Although human trypsin-2 efficiently digested type II collagen, bovine trypsin did not. Furthermore, immunohistochemical staining detected trypsin-2 in the fibroblast-like synovial lining and in stromal cells of human rheumatoid arthritis synovial membrane. These findings were confirmed by reverse transcriptase-polymerase chain reaction and nucleotide sequencing. Trypsin-2 alone and complexed with alpha(1)-proteinase inhibitor were also detected in the synovial fluid of affected joints by time-resolved immunofluorometric assay, suggesting that trypsin-2 is activated locally. These results are the first to assess the ability of human trypsin to cleave human type II collagen. Thus, trypsin-2 and its regulators should be further studied for use as markers of prognosis and disease activity in rheumatoid arthritis.
Asunto(s)
Artritis Reumatoide/metabolismo , Colágeno Tipo II/metabolismo , Inhibidor de Tripsina Pancreática de Kazal/farmacología , Tripsina/farmacología , Tripsinógeno/farmacología , Adulto , Anciano , Anciano de 80 o más Años , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales/metabolismo , Artritis Reumatoide/patología , Secuencia de Bases , Bovinos , Técnicas de Cultivo de Célula , Células Cultivadas , Colágeno Tipo II/análisis , Colágeno Tipo II/química , Colágeno Tipo II/genética , Electroforesis en Gel de Poliacrilamida , Europio , Femenino , Fluorometría , Humanos , Inmunohistoquímica , Masculino , Espectrometría de Masas , Metaloproteinasa 8 de la Matriz/farmacología , Persona de Mediana Edad , Datos de Secuencia Molecular , Peso Molecular , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Líquido Sinovial/citología , Líquido Sinovial/metabolismo , Membrana Sinovial/metabolismo , Membrana Sinovial/patología , Tripsina/análisis , Tripsina/química , Tripsina/aislamiento & purificación , Tripsina/orina , Inhibidor de Tripsina Pancreática de Kazal/análisis , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Inhibidor de Tripsina Pancreática de Kazal/orina , Tripsinógeno/aislamiento & purificación , Tripsinógeno/orinaRESUMEN
The plant apoplast forms a protease-rich environment in which proteases are integral components of the plant defense response. Plant pathogenic oomycetes, such as the potato (Solanum tuberosum) and tomato (Lycopersicon esculentum) pathogen Phytophthora infestans, secrete a diverse family of serine protease inhibitors of the Kazal family. Among these, the two-domain EPI1 protein was shown to inhibit and interact with the pathogenesis-related protein P69B subtilase of tomato and was implicated in counter-defense. Here, we describe and functionally characterize a second extracellular protease inhibitor, EPI10, from P. infestans. EPI10 contains three Kazal-like domains, one of which was predicted to be an efficient inhibitor of subtilisin A by an additivity-based sequence to reactivity algorithm (Laskowski algorithm). The epi10 gene was up-regulated during infection of tomato, suggesting a potential role during pathogenesis. Recombinant EPI10 specifically inhibited subtilisin A among the major serine proteases, and inhibited and interacted with P69B subtilase of tomato. The finding that P. infestans evolved two distinct and structurally divergent protease inhibitors to target the same plant protease suggests that inhibition of P69B could be an important infection mechanism for this pathogen.
Asunto(s)
Péptido Hidrolasas/metabolismo , Phytophthora/patogenicidad , Solanum lycopersicum/microbiología , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Secuencia de Aminoácidos , Secuencia de Bases , Quimotripsina/metabolismo , Cartilla de ADN , Datos de Secuencia Molecular , Péptido Hidrolasas/química , Péptido Hidrolasas/genética , Phytophthora/química , Enfermedades de las Plantas/microbiología , Proteínas de Plantas/antagonistas & inhibidores , Proteínas de Plantas/química , Mapeo Restrictivo , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Subtilisinas/antagonistas & inhibidores , Tripsina/metabolismo , Inhibidor de Tripsina Pancreática de Kazal/farmacologíaRESUMEN
A chymotrypsin inhibitor of the Kazal-type has been isolated from duck pancreas, by affinity chromatography on immobilized chymotrypsin, gel filtration on Bio-Gel P-10 and reverse phase (RP)-HPLC. It inhibits bovine chymotrypsin Aalpha with an association constant (K(a)) of 2.06x10(7) M(-1). The complete amino acid sequence was determined after digestion of pyridylethylated inhibitor with Staphylococcus aureus V8 protease and chemical cleavage with CNBr. Duck pancreatic chymotrypsin inhibitor (DPCI) was found to be a single polypeptide chain composed of 65 amino acid residues, corresponding to a molecular mass of 7191 Da.
Asunto(s)
Quimotripsina/antagonistas & inhibidores , Patos , Páncreas/química , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Secuencia de Aminoácidos , Animales , Cromatografía de Afinidad , Cromatografía Líquida de Alta Presión , Electroforesis en Gel de Poliacrilamida , Humanos , Datos de Secuencia Molecular , Homología de Secuencia de Aminoácido , Inhibidor de Tripsina Pancreática de Kazal/química , Inhibidor de Tripsina Pancreática de Kazal/metabolismoRESUMEN
The bile concentrations of trypsinogen-1, -2 and tumour-associated trypsin-inhibitor (TATI) were determined in 23 patients with benign biliary tract disease, two with biliary tract cancer, and in 15 with pancreatic cancer. We also examined the trypsinogen and TATI expression by immunohistochemistry in tissue specimens from biliary tract cancer and non-neoplastic extrahepatic biliary tract. High levels of trypsinogen-1, trypsinogen-2, and TATI occur in bile of most patients. In contrast to the trypsinogens, the levels of TATI were significantly higher in patients with malignant disease than in those with benign diseases (p=0.04). There was no significant correlation between trypsinogen-2 and amylase (r=0.13, p=0.40), indicating that the occurrence of trypsinogen in bile is not a result of reflux of pancreatic fluid into the bile duct. Immunohistochemically, trypsinogen-2 was detected in five and TATI in 12 out of 15 non-neoplastic biliary tract specimens, and in four and seven out of 11 cholangiocarcinomas, respectively. High concentrations of trypsinogen-1, trypsinogen-2 and TATI occur in the bile of patients with non-neoplastic and malignant biliary tract disease and in patients with pancreatic cancer. At least part of the trypsinogen-2 and TATI found in bile appears to be derived from the biliary epithelium itself.
Asunto(s)
Bilis/metabolismo , Enfermedades de las Vías Biliares/metabolismo , Sistema Biliar/metabolismo , Neoplasias Pancreáticas/metabolismo , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Tripsina , Tripsinógeno/aislamiento & purificación , HumanosRESUMEN
A Kazal-type elastase inhibitor was purified by trichloroacetic acid precipitation of sheep lung lavage fluid followed by chymotrypsin affinity and gel-filtration chromatography of the supernatant. Sheep lung elastase inhibitor (SLEI) is glycosylated. Laser desorption mass spectrometry indicated that SLEI has a molecular mass of 16.8-17.3 kDa. Partial protein sequence of SLEI and of a peptide derived from SLEI showed 31-52% and 51-66% homology at the N-terminus and at the inhibitory site respectively with Kazal-type double-headed proteinase inhibitors (bikazins). SLEI inhibited human leukocyte elastase and porcine pancreatic elastase but not human cathepsin G. It was inactivated by chloramine-T and reactivated when incubated with methionine sulfoxide peptide reductase and dithiothreitol, indicating the presence of a methionine at the active site. The concentration of SLEI in bronchoalveolar lavage fluid (BALF) and lung lymph was 0.28 microM (0.23-0.49); 0.24 microM (0.20-0.31) (median, (range), n = 5), respectively and was undetectable in plasma (< 0.03 microM) suggesting that SLEI is produced in the lung. The median molar ratios of SLEI to alpha1-proteinase inhibitor in BALF and lung lymph were 3.2 to 1 and 0.017 to 1, respectively. These results indicate that SLEI probably makes an important contribution to antielastase defence in epithelial lining liquid.
Asunto(s)
Elastasa de Leucocito/antagonistas & inhibidores , Pulmón/fisiología , Inhibidores de Serina Proteinasa/química , Inhibidores de Serina Proteinasa/farmacología , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Inhibidor de Tripsina Pancreática de Kazal/farmacología , Secuencia de Aminoácidos , Animales , Carnívoros , Catepsina G , Catepsinas/antagonistas & inhibidores , Cromatografía de Afinidad , Cromatografía en Gel , Quimotripsina , Perros , Zorros , Humanos , Pulmón/química , Visón , Datos de Secuencia Molecular , Peso Molecular , Oxidación-Reducción , Páncreas/enzimología , Elastasa Pancreática/antagonistas & inhibidores , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Serina Endopeptidasas , Inhibidores de Serina Proteinasa/aislamiento & purificación , Ovinos , Porcinos , Irrigación Terapéutica , Inhibidor de Tripsina Pancreática de Kazal/químicaRESUMEN
Ostrich pancreatic secretory trypsin inhibitor was isolated and purified using acid extraction, salt fractionation. SP-Sephadex C-50 and QAE-Sephadex A-25 chromatography and RP-HPLC. The amino acid sequence of ostrich PSTI showed it is a single peptide chain containing 69 amino acid residues with the highest homology between ostrich and chicken PSTI. The molecular weight, as determined by electronspray mass spectrometry and from amino acid sequence data, is 7650 Da. The isoelectric point of ostrich PSTI was found to be 5.7. Ostrich PSTI specifically inhibited ostrich and commercial bovine trypsin with Ki values of 8.0 x 10(-9) and 2.4 x 10(-7) M, respectively, while no inhibitory effects were observed with other serine proteases.
Asunto(s)
Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Secuencia de Aminoácidos , Animales , Aves , Carboxipeptidasas/metabolismo , Cromatografía Líquida de Alta Presión , Cromatografía por Intercambio Iónico , Quimotripsina/metabolismo , Electroforesis en Gel de Poliacrilamida , Focalización Isoeléctrica , Datos de Secuencia Molecular , Elastasa Pancreática/metabolismo , Homología de Secuencia de Aminoácido , Tripsina/metabolismo , Inhibidor de Tripsina Pancreática de Kazal/metabolismoRESUMEN
The Ser-170 residue of a trypsin-like enzyme from Streptomyces fradiae (SFT), which is considered to be the active-site serine, was replaced with alanine by site-directed mutagenesis to improve the affinity chromatography step for a Kazal-type trypsin inhibitor pancreatic secretory trypsin inhibitor (PSTI). The resulting mutant SFT, designated as [S170A]SFT, was expressed in Streptomyces lividans and purified to homogeneity. [S170A]SFT was catalytically inactive, but still had the ability to bind tightly to PSTI and to soybean trypsin inhibitor with dissociation constants of 3.1 x 10(-7) M and 1.9 x 10(-8) M respectively. We further demonstrated that recombinant human PSTI secreted into Saccharomyces cerevisiae culture broth could be purified to homogeneity with a one-step [S170A]SFT-affinity column. The purified PSTI contained no molecules intramolecularly cleaved by active trypsin, which are found when trypsin-affinity chromatography is used for the purification. This eliminated the need for further separation of intact PSTI from intramolecularly cleaved PSTI by high-performance liquid chromatography, thus simplifying and improving its purification process.
Asunto(s)
Cromatografía de Afinidad/métodos , Streptomyces/enzimología , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Inhibidores de Tripsina/aislamiento & purificación , Tripsina , Humanos , Cinética , Mutagénesis Sitio-Dirigida , Unión Proteica , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Tripsina/genética , Tripsina/metabolismo , Inhibidor de Tripsina Pancreática de Kazal/metabolismo , Inhibidores de Tripsina/metabolismoRESUMEN
A trypsin inhibitor of Kazal type has been isolated from goose pancreas by affinity chromatography on immobilized anhydrotrypsin, anion exchange and reverse phase HPLC. It inhibits bovine beta-trypsin with the association constant (Ka) of 5.99 x 10(8) M-1. The complete amino-acid sequence was determined following CNBr treatment. The protein comprised a total of 69 amino-acid residues, corresponding to a molecular mass of 7.7 kDa. The P1-P'1 reactive site bond of the inhibitor was localized at position Lys25-Met26. The amino-acid sequence of GPTI shows extremely high homology to that of other inhibitors isolated from pancreas of birds.
Asunto(s)
Páncreas/metabolismo , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Secuencia de Aminoácidos , Animales , Cromatografía Líquida de Alta Presión , Cromatografía por Intercambio Iónico , Electroforesis en Gel de Poliacrilamida , Gansos , Humanos , Hidrólisis , Datos de Secuencia Molecular , Homología de Secuencia de Aminoácido , Inhibidor de Tripsina Pancreática de Kazal/química , Inhibidor de Tripsina Pancreática de Kazal/metabolismoRESUMEN
A cDNA with an open reading frame of 684 base pairs was isolated from a library from blood cells of the crayfish Pacifastacus leniusculus. It codes for a signal sequence and a mature protein of 209 amino acids with a predicted molecular mass of 22.7 kDa. The amino acid sequence consists of four repeated stretches (45-73% identical to each other), indicating that the protein has four domains. The domains have significant sequence similarity to serine proteinase inhibitors of the Kazal family. The three first domains have a leucine residue in the putative reactive site, suggesting that the protein is a chymotrypsin inhibitor. A monomeric 23-kDa proteinase inhibitor, which by amino terminal sequencing of the mature protein was confirmed to be the cloned Kazal inhibitor, was purified from crayfish blood cells. It inhibited chymotrypsin or subtilisin, but not trypsin, elastase or thrombin. The inhibitor seemed to form a 1:1 complex with chymotrypsin or subtilisin. This protein seems to be the first described Kazal inhibitor from blood cells of any animal and the first one with four domains.
Asunto(s)
Astacoidea/química , ADN Complementario/genética , Inhibidor de Tripsina Pancreática de Kazal/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Células Sanguíneas/química , Clonación Molecular , Electroforesis en Gel de Poliacrilamida , Datos de Secuencia Molecular , Peso Molecular , Alineación de Secuencia , Inhibidor de Tripsina Pancreática de Kazal/sangre , Inhibidor de Tripsina Pancreática de Kazal/química , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificaciónRESUMEN
A thrombin-specific inhibitor with an apparent molecular mass of 11 kDa has been purified from the insect Rhodnius prolixus. Amino-terminal protein sequence analysis allowed the molecular cloning of the corresponding cDNA. The open reading frame codes for a protein of about 103 amino acid residues and displays an internal sequence homology of residues 6-48 with residues 57-101 indicating a two-domain structure. Based on the amino acid sequence the two domains exhibit high homology to protease inhibitors belonging to the Kazal-type family. Model building suggests that the first domain binds to the active site with residue His10 pointing into the specificity pocket. From gel filtration and tight-binding inhibition experiments the inhibitor appears to form 1:1 complexes with thrombin. Periplasma-directed heterologous expression of the rhodniin cDNA in Escherichia coli yields the intact thrombin inhibitor. Natural and recombinant rhodniin both display inhibition constants of about 2 x 10(-13) M.
Asunto(s)
Hormonas de Insectos/genética , Proteínas de Insectos , Rhodnius/química , Trombina/antagonistas & inhibidores , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Clonación Molecular , ADN , Hormonas de Insectos/metabolismo , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Inhibidores de Proteasas/aislamiento & purificación , Inhibidores de Proteasas/metabolismo , Homología de Secuencia de Aminoácido , Inhibidor de Tripsina Pancreática de Kazal/química , Inhibidor de Tripsina Pancreática de Kazal/genética , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Inhibidor de Tripsina Pancreática de Kazal/metabolismoRESUMEN
Pancreatic exocrine secretion in the conscious rat is regulated by proteases in the intestine secreted by the pancreas, and cholecystokinin (CCK) is known to be involved in the mechanism. The authors proposed that the release of CCK was regulated by a CCK-releasing factor secreted into the intestinal lumen from the proximal intestine. We isolated and partially purified a CCK-releasing factor from rat small intestine by gel filtration and high performance liquid chromatography. The partially purified CCK-releasing factor increased pancreatic exocrine secretions and plasma CCK concentrations in conscious rats and this activity was abolished after the incubation with trypsin. The bioactivity of the partially purified CCK-releasing factor was confirmed.
Asunto(s)
Duodeno/metabolismo , Hormonas Gastrointestinales/aislamiento & purificación , Hormonas Gastrointestinales/metabolismo , Sustancias de Crecimiento , Péptidos y Proteínas de Señalización Intercelular , Mucosa Intestinal/metabolismo , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Inhibidor de Tripsina Pancreática de Kazal/metabolismo , Animales , Cromatografía en Gel , Cromatografía Líquida de Alta Presión , Retroalimentación/fisiología , Masculino , Páncreas/metabolismo , Ratas , Ratas EndogámicasRESUMEN
A Kazal-type trypsin inhibitor in mouse seminal vesicle secretion was purified to homogeneity via a series of purification steps including ammonium sulfate fractionation, affinity chromatography on a trypsin Affi-Gel 10 column, and HPLC on a reverse phase C4 column. It was shown to be a weak basic protein with an isoelectric point of 8.7 and to contain no carbohydrate. The protein had a specific activity of 184 U/mg protein in the inhibitory effect on the trypsin digestion of N-benzoyl-Pro-Phe-Arg-p-nitroanilide. Analysis of the kinetic data for the trypsin digestion of N-benzoyl-Phe-Val-Arg 7-amido-4-methylcoumarin revealed that the protein was a competitive inhibitor with an inhibitory constant (Ki) of 0.15 nM. The molecular mass of the protein was determined to be 7 kDa by both gel chromatography and electrophoresis. Results of direct amino acid determinations indicated that this protein corresponded to the reading frame of MP12 cDNA identified from mouse prostate. We found that cleavage only at the reactive site of this protein (Arg19-Ile20) resulted in its denaturation.
Asunto(s)
Vesículas Seminales/química , Inhibidor de Tripsina Pancreática de Kazal/química , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Cromatografía Líquida de Alta Presión , Masculino , Ratones , Ratones Endogámicos ICR , Datos de Secuencia Molecular , Peso Molecular , Vesículas Seminales/metabolismo , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificaciónRESUMEN
Tetragonal and triclinic crystals of two ovomucoid inhibitor third domains from silver pheasant and Japanese quail, modified at their reactive site bonds Met18-Glu19 (OMSVP3*) and Lys18-Asp19 (OMJPQ3*), respectively, were obtained. Their molecular and crystal structures were solved using X-ray data to 2.5 A and 1.55 A by means of Patterson search methods using truncated models of the intact (virgin) inhibitors as search models. Both structures were crystallographically refined to R-values of 0.185 and 0.192, respectively, applying an energy restraint reciprocal space refinement procedure. Both modified inhibitors show large deviations from the intact derivatives only in the proteinase binding loops (Pro14 to Arg21) and in the amino-terminal segments (Leu1 to Val6). In the modified inhibitors the residues immediately adjacent to the cleavage site (in particular P2, P1, P1') are mobile and able to adapt to varying crystal environments. The charged end-groups, i.e. Met18 COO- and Glu19 NH3+ in OMSVP3*, and Lys18 COO- and Asp19 NH3+ in OMJPQ3*, do not form ion pairs with one another. The hydrogen bond connecting the side-chains of Thr17 and Glu19 (i.e. residues on either side of the scissile peptide bond) in OMSVP3 is broken in the modified form, and the hydrogen-bond interactions observed in the intact molecules between the Asn33 side-chain and the carbonyl groups of loop residues P2 and P1' are absent or weak in the modified inhibitors. The reactive site cleavage, however, has little effect on specific interactions within the protein scaffold such as the side-chain hydrogen bond between Asp27 and Tyr31 or the side-chain stacking of Tyr20 and Pro22. The conformational differences in the amino-terminal segment Leu1 to Val6 are explained by their ability to move freely, either to associate with segments of symmetry-related molecules under formation of a four-stranded beta-barrel (OMSVP3* and OMJPQ3) or to bind to surrounding molecules. Together with the results given in the accompanying paper, these findings probably explain why Khyd of small protein inhibitors of serine proteinases is generally found to be so small.
Asunto(s)
Ovomucina/antagonistas & inhibidores , Inhibidor de Tripsina Pancreática de Kazal/química , Secuencia de Aminoácidos , Animales , Sitios de Unión , Aves , Simulación por Computador , Coturnix , Cristalización , Hidrólisis , Modelos Moleculares , Datos de Secuencia Molecular , Conformación Proteica , Inhibidor de Tripsina Pancreática de Kazal/aislamiento & purificación , Difracción de Rayos X/métodosRESUMEN
Upon investigation of pig intestinal peptides for effects on the release of endocrine hormones from the isolated perfused rat pancreas, we reported earlier that glucose-stimulated insulin release was inhibited by PEC-60, a peptide with marked sequence similarity to PSTI (pancreatic secretory trypsin inhibitor). Continuing this study we found a polypeptide, which inhibited glucose-induced insulin release but enhanced glucose-induced somatostatin secretion. Determination of the amino acid sequence of this polypeptide revealed that it is identical to that of PSTI. Thus, PSTI modulates islet hormone release.